Accepted for Publication: April 6, 2022.
Published: June 9, 2022. doi:10.1001/jamanetworkopen.2022.15787
Open Access: This is an open access article distributed under the terms of the CC-BY-NC-ND License. © 2022 Edlow AG et al. JAMA Network Open.
Corresponding Author: Roy H. Perlis, MD, MSc, Center for Quantitative Health and Department of Psychiatry, Massachusetts General Hospital, 185 Cambridge St, Simches Research Building, Boston, MA 02114 (firstname.lastname@example.org).
Author Contributions: Dr Perlis had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Castro, Kaimal, Perlis.
Acquisition, analysis, or interpretation of data: Edlow, Castro, Shook, Perlis.
Drafting of the manuscript: Edlow, Castro, Perlis.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Castro, Perlis.
Administrative, technical, or material support: Edlow, Castro, Kaimal.
Conflict of Interest Disclosures: Dr Edlow reported receiving grants from Simons Foundation during the conduct of the study. Dr Perlis reported receiving consulting fees from Burrage Capital, Genomind, RID Ventures, Belle Artificial Intelligence, and Takeda; he reported receiving equity in Psy Therapeutics, Belle Artificial Intelligence, and Circular Genomics; Dr Perlis also reported receiving personal fees from Genomind Scientific Advisory Board and personal fees from Vault Health Scientific Advisory Board outside the submitted work. No other disclosures were reported.
Funding/Support: This study was supported by the National Institute of Mental Health (R01MH116270 and 1R56MH115187; Dr Perlis) and the National Institute of Child Health and Human Development (R01 HD100022-02S2; Dr Edlow).
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Disclaimer: Dr Perlis is an associate editor for JAMA Network Open but was not involved in the editorial review or decision for this manuscript.
A , Jarskog
LF , Lieberman
JA , Gilmore
JH . Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain. Schizophr Res
. 2001;47(1):27-36. doi:10.1016/s0920-9964(00)00032-3Google ScholarCrossref
JP , Watson
CJ , Badenoch
et al. Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives. J Neurol Neurosurg Psychiatry
. 2021;92(9):932-941. doi:10.1136/jnnp-2021-326405PubMedGoogle ScholarCrossref
VM , Rosand
J , Giacino
JT , McCoy
TH , Perlis
RH . Case-control study of neuropsychiatric symptoms following COVID-19 hospitalization in 2 academic health systems. medRxiv
. Preprint posted online July 14, 2021. doi:10.1101/2021.07.09.21252353Google Scholar
M , Geddes
JR , Husain
M , Luciano
S , Harrison
PJ . 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry
. 2021;8(5):416-427. doi:10.1016/S2215-0366(21)00084-5PubMedGoogle ScholarCrossref
VM , Gunning
FM , Perlis
RH . Persistence of neuropsychiatric symptoms associated with SARS-CoV-2 positivity among a cohort of children and adolescents. medRxiv
. Preprint posted online September 29, 2021. doi:10.1101/2021.09.28.21264259Google Scholar
TD , Clifton
RG , Hughes
et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Disease severity and perinatal outcomes of pregnant patients with coronavirus disease 2019 (COVID-19). Obstet Gynecol
. 2021;137(4):571-580. doi:10.1097/AOG.0000000000004339PubMedGoogle ScholarCrossref
KR , Olsen
EO , Neelam
et al; CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team; COVID-19 Pregnancy and Infant Linked Outcomes Team (PILOT). Birth and infant outcomes following laboratory-confirmed SARS-CoV-2 infection in pregnancy - SET-NET, 16 jurisdictions, March 29-October 14, 2020. MMWR Morb Mortal Wkly Rep
. 2020;69(44):1635-1640. doi:10.15585/mmwr.mm6944e2PubMedGoogle ScholarCrossref
LC , Firestein
MR , Kyle
et al. Birth during the COVID-19 Pandemic, but not maternal SARS-CoV-2 infection during pregnancy, is associated with lower neurodevelopmental scores at 6-months. JAMA Pediatr
. Published online January 4, 2022. doi:10.1001/jamapediatrics.2021.5563Google ScholarCrossref